Multi-synergetic ZnO platform for high performance cancer therapy

  • Nirmalya Tripathy
  • , Rafiq Ahmad
  • , Hyun Ah Ko
  • , Gilson Khang
  • , Yoon Bong Hahn*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

Abstract

ZnO platforms were evaluated for designing a high-performance anticancer drug (daunorubicin) carrier. Hollow structured ZnO, compared with nanorods, acts as a multi-purpose entity by serving as smart carriers and exhibiting synergetic photodynamic cytotoxic effects, which are ascribed to their high-specific surface area, hollow interior, pH-responsiveness and inherent photodynamism.

Original languageEnglish
Pages (from-to)2585-2588
Number of pages4
JournalChemical Communications
Volume51
Issue number13
DOIs
StatePublished - 2015.02.14

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Quacquarelli Symonds(QS) Subject Topics

  • Materials Science
  • Engineering - Petroleum
  • Engineering - Chemical
  • Chemistry

Fingerprint

Dive into the research topics of 'Multi-synergetic ZnO platform for high performance cancer therapy'. Together they form a unique fingerprint.

Cite this